Investment opportunities

54
remaining days
Target
€2.150.000
Invested
90.4%

Aspivix

flag

Aspivix introduces a non-invasive alternative to the cervical tenaculum, improving accessibility to effective contraception

24
remaining days
Target
€500.000
Invested
59.1%

24Genetics

flag

The combination of Genetics and Artificial Intelligence will revolutionize health and well-being

40
remaining days
Target
€1.000.000
Invested
104.7%

MgShell

flag

Facilitating chronic eye treatment with a new controlled drug release device

40
remaining days
Target
€650.000
Invested
76.9%

VB Devices

flag

VB Devices automates sclerotherapy with VARIXIO, improving safety, efficacy and consistency of treatment.

43
remaining days
Target
€700.000
Invested
36.5%

VERIGRAFT

flag

VERIGRAFT pioneers natural personalized tissue therapies to cure severe and chronic diseases

11
remaining days
Target
€600.000
Invested
87.3%

Digital Anatomics

flag

We create personalized medical devices for spinal surgery, combining biomechanical engineering and artificial intelligence.

40
remaining days
Target
€2.300.000
Invested
97.3%

OxyPrem AG

flag

OxyPrem's sensors help to protect prematurely-born children from brain damage and life-long disabilities.

Successfully closed!
Target
€1.100.000
Invested
103.9%

DyCare

flag

Successfully closed!
Target
€500.000
Invested
114.6%

Arjuna Therapeutics

flag

Arjuna develops a new molecule for metastatic cancers with limited therapeutic options.

Successfully closed!
Target
€2.000.000
Invested
115.2%

Pharmamel

flag

Development of new melatonin-based drugs for sepsis, inflammatory, and viral diseases.

Successfully closed!
Target
€750.000
Invested
113.4%

EktaH

flag

EktaH creates new therapeutic solutions to combat overweight and obesity globally.

Successfully closed!
Target
€1.200.000
Invested
110.2%

Hemerion

flag

Hemerion develops unique light-based therapies to extend and save lives of cancer patients.